🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This pilot clinical trial studies the feasibility of choosing treatment bas...
Status
Completed
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2015-09-11
Trial ID
NCT02551718
The goal of this clinical trial is to learn about the tolerability of telmi...
Status
Recruiting
Location
Dartmouth Health
Start Date
2024-04-22
Trial ID
NCT06168487
Treatments Being Tested
To find the best dose of ADI-PEG20 that can be given in combination with ca...
Status
Recruiting
Location
MD Anderson Cancer Center
Start Date
2024-02-29
Trial ID
NCT06085729
Treatments Being Tested
26 patients with invasive primary transitional cell carcinoma of the bladde...
Status
Completed
Location
Bristol Haematology + Oncology Centre, Horfield Road
Start Date
2012-07-25
Trial ID
NCT01616875
Treatments Being Tested
There is no accepted standard chemotherapy approved for use in the second l...
Status
Completed
Location
National Cancer Institute
Start Date
2012-02-16
Trial ID
NCT01437488
Treatments Being Tested
Primary Objective: \- To evaluate the anti-tumor activity of cabazitaxel b...
Status
Completed
Location
Investigational Site Number 410001
Start Date
2011-12
Trial ID
NCT01497964
Treatments Being Tested
This is a Phase Ib/IIa Study of Cabazitaxel plus Bavituximab in patients wi...
Status
Terminated
Location
Medical University of South Carolina
Start Date
2011-06
Trial ID
NCT01335204
Treatments Being Tested
Cabazitaxel will be administered 20 mg/m2 IV over 1 hour every 3 weeks, as ...
Status
Completed
Location
UCSF Comprehensive Cancer Center
Start Date
2012-12
Trial ID
NCT01757171
Treatments Being Tested
The standard of care for men with metastatic CRPC in 2010 following progres...
Status
Completed
Location
The University of Chicago
Start Date
2012-01
Trial ID
NCT01513733
Treatments Being Tested
Primary Objective: \- To assess effectiveness of prophylactic treatment of...
Status
Completed
Location
Investigational Site Number 007
Start Date
2012-07
Trial ID
NCT01649635
Treatments Being Tested